Sponsor Pipeline

Appello Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-21 NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to…		 Trial sites expanded: 25 -> 30 locations
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07432958 A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to… Parkinson Disease Recruiting
Disease Areas
Parkinson's Disease (1)
Get alerts when Appello Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free